First evidence of PSMA expression in differentiated thyroid cancer using [⁶⁸Ga]PSMA-HBED-CC PET/CT.
Department of Nuclear Medicine, RWTH University Hospital Aachen, Pauwelsstraße 30, 52074, Aachen, Germany, fverburg@ukaachen.de.
Frederik A
FA
Verburg
Thomas
T
Krohn
Alexander
A
Heinzel
Felix M
FM
Mottaghy
Florian F
FF
Behrendt
D000954:Antigens, Surface / Q000378:metabolism*; D014408:Biomarkers, Tumor / Q000378:metabolism*; D004492:Edetic Acid / Q000031:analogs & derivatives / Q000493:pharmacokinetics; D019317:Evidence-Based Medicine; D005710:Gallium Radioisotopes; D043425:Glutamate Carboxypeptidase II / Q000378:metabolism*; D006801:Humans; D057054:Molecular Imaging / Q000379:methods; D064847:Multimodal Imaging / Q000379:methods; D010865:Pilot Projects; D049268:Positron-Emission Tomography / Q000379:methods*; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity; D013964:Thyroid Neoplasms / Q000175:diagnosis* / Q000378:metabolism*; D014057:Tomography, X-Ray Computed / Q000379:methods*
D000954:Antigens, Surface; D014408:Biomarkers, Tumor; D005710:Gallium Radioisotopes; C075313:N,N'-bis(2-hydroxy-5-(ethylene-beta-carboxy)benzyl)ethylenediamine N,N'-diacetic acid; D004492:Edetic Acid; C473848:FOLH1 protein, human; D043425:Glutamate Carboxypeptidase II